Evaluation of a Booster Administration of GAD-alum (Diamyd®) in Individuals With Type 1 Diabetes

NCT05351879 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

6

Enrollment

OTHER_GOV

Sponsor class

Conditions

Diabetes Mellitus, Type 1

Interventions

BIOLOGICAL: GAD-alum (Diamyd) 40 μg/mL

Sponsor

Linkoeping University

Collaborators

[object Object]